These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11551583)

  • 21. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
    Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma.
    Dempsey MF; Wyper D; Owens J; Pimlott S; Papanastassiou V; Patterson J; Hadley DM; Nicol A; Rampling R; Brown SM
    Nucl Med Commun; 2006 Aug; 27(8):611-7. PubMed ID: 16829761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene.
    Germann C; Shields AF; Grierson JR; Morr I; Haberkorn U
    J Nucl Med; 1998 Aug; 39(8):1418-23. PubMed ID: 9708520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by [(123)I]FIAU(1).
    Choi SR; Zhuang ZP; Chacko AM; Acton PD; Tjuvajev-Gelovani J; Doubrovin M; Chu DC; Kung HF
    Acad Radiol; 2005 Jul; 12(7):798-805. PubMed ID: 16039533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
    Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
    J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
    Shand N; Weber F; Mariani L; Bernstein M; Gianella-Borradori A; Long Z; Sorensen AG; Barbier N
    Hum Gene Ther; 1999 Sep; 10(14):2325-35. PubMed ID: 10515452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir.
    Deng WP; Wu CC; Lee CC; Yang WK; Wang HE; Liu RS; Wei HJ; Gelovani JG; Hwang JJ; Yang DM; Fu YK; Wu CW
    J Nucl Med; 2006 May; 47(5):877-84. PubMed ID: 16644759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The biosafety of the HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
    Adachi N; Könü DL; Frei K; Yonekawa Y
    No Shinkei Geka; 2000 Nov; 28(11):965-74. PubMed ID: 11127592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.
    Koehne G; Doubrovin M; Doubrovina E; Zanzonico P; Gallardo HF; Ivanova A; Balatoni J; Teruya-Feldstein J; Heller G; May C; Ponomarev V; Ruan S; Finn R; Blasberg RG; Bornmann W; Riviere I; Sadelain M; O'Reilly RJ; Larson SM; Tjuvajev JG
    Nat Biotechnol; 2003 Apr; 21(4):405-13. PubMed ID: 12652311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial kinetics of reporter probe 124I-FIAU in isolated perfused rat hearts after in vivo adenoviral transfer of herpes simplex virus type 1 thymidine kinase reporter gene.
    Simões MV; Miyagawa M; Reder S; Städele C; Haubner R; Linke W; Lehner T; Epple P; Anton M; Schwaiger M; Bengel FM
    J Nucl Med; 2005 Jan; 46(1):98-105. PubMed ID: 15632039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase.
    Moriuchi S; Glorioso JC; Maruno M; Izumoto S; Wolfe D; Huang S; Cohen JB; Yoshimine T
    Cancer Gene Ther; 2005 May; 12(5):487-96. PubMed ID: 15692608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
    Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
    Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
    Pasanen T; Karppinen A; Alhonen L; Jänne J; Wahlfors J
    Int J Cancer; 2003 Apr; 104(3):380-8. PubMed ID: 12569563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir.
    Gambhir SS; Barrio JR; Wu L; Iyer M; Namavari M; Satyamurthy N; Bauer E; Parrish C; MacLaren DC; Borghei AR; Green LA; Sharfstein S; Berk AJ; Cherry SR; Phelps ME; Herschman HR
    J Nucl Med; 1998 Nov; 39(11):2003-11. PubMed ID: 9829598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of cellular kinetics of reporter probe [(131)I]FIAU in neonatal cardiac myocytes after transfer of HSV1-tk reporter gene with two vectors.
    Lan X; Yin X; Wang R; Liu Y; Zhang Y
    Nucl Med Biol; 2009 Feb; 36(2):207-13. PubMed ID: 19217533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.
    Bevilacqua F; Davis-Poynter N; Worrallo J; Gower D; Collins P; Darby G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1927-35. PubMed ID: 7636473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo evaluation of the uptake of [(123)I]FIAU, [(123)I]IVFRU and [(123)I]IVFAU by normal mouse brain: potential for noninvasive assessment of HSV-1 thymidine kinase gene expression in gliomas.
    Li HF; Winkeler A; Moharram S; Knaus EE; Dittmar K; Stöckle M; Heiss WD; Wiebe LI; Jacobs AH
    Nucleosides Nucleotides Nucleic Acids; 2008 Jan; 27(1):57-66. PubMed ID: 18188770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein.
    Sethi N; Palefsky J
    Hum Gene Ther; 2003 Jan; 14(1):45-57. PubMed ID: 12573058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.